These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1887 related articles for article (PubMed ID: 32637987)

  • 1. The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings.
    Paterson RW; Brown RL; Benjamin L; Nortley R; Wiethoff S; Bharucha T; Jayaseelan DL; Kumar G; Raftopoulos RE; Zambreanu L; Vivekanandam V; Khoo A; Geraldes R; Chinthapalli K; Boyd E; Tuzlali H; Price G; Christofi G; Morrow J; McNamara P; McLoughlin B; Lim ST; Mehta PR; Levee V; Keddie S; Yong W; Trip SA; Foulkes AJM; Hotton G; Miller TD; Everitt AD; Carswell C; Davies NWS; Yoong M; Attwell D; Sreedharan J; Silber E; Schott JM; Chandratheva A; Perry RJ; Simister R; Checkley A; Longley N; Farmer SF; Carletti F; Houlihan C; Thom M; Lunn MP; Spillane J; Howard R; Vincent A; Werring DJ; Hoskote C; Jäger HR; Manji H; Zandi MS
    Brain; 2020 Oct; 143(10):3104-3120. PubMed ID: 32637987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians.
    Maury A; Lyoubi A; Peiffer-Smadja N; de Broucker T; Meppiel E
    Rev Neurol (Paris); 2021; 177(1-2):51-64. PubMed ID: 33446327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurological associations of COVID-19.
    Ellul MA; Benjamin L; Singh B; Lant S; Michael BD; Easton A; Kneen R; Defres S; Sejvar J; Solomon T
    Lancet Neurol; 2020 Sep; 19(9):767-783. PubMed ID: 32622375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic.
    Rogers JP; Chesney E; Oliver D; Pollak TA; McGuire P; Fusar-Poli P; Zandi MS; Lewis G; David AS
    Lancet Psychiatry; 2020 Jul; 7(7):611-627. PubMed ID: 32437679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neurology of COVID-19 revisited: A proposal from the Environmental Neurology Specialty Group of the World Federation of Neurology to implement international neurological registries.
    Román GC; Spencer PS; Reis J; Buguet A; Faris MEA; Katrak SM; Láinez M; Medina MT; Meshram C; Mizusawa H; Öztürk S; Wasay M;
    J Neurol Sci; 2020 Jul; 414():116884. PubMed ID: 32464367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outpatient treatment of COVID-19 with steroids in the phase of mild pneumonia without the need for admission as an opportunity to modify the course of the disease: A structured summary of a randomised controlled trial.
    Saiz-Rodríguez M; Peña T; Lázaro L; González Á; Martínez A; Cordero JA; Vicente JT; Richard F; Coma MJ; de Frutos M; Labrador J; Pueyo A
    Trials; 2020 Jul; 21(1):632. PubMed ID: 32646502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological manifestations of coronavirus infections - a systematic review.
    Almqvist J; Granberg T; Tzortzakakis A; Klironomos S; Kollia E; Öhberg C; Martin R; Piehl F; Ouellette R; Ineichen BV
    Ann Clin Transl Neurol; 2020 Oct; 7(10):2057-2071. PubMed ID: 32853453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study.
    Varatharaj A; Thomas N; Ellul MA; Davies NWS; Pollak TA; Tenorio EL; Sultan M; Easton A; Breen G; Zandi M; Coles JP; Manji H; Al-Shahi Salman R; Menon DK; Nicholson TR; Benjamin LA; Carson A; Smith C; Turner MR; Solomon T; Kneen R; Pett SL; Galea I; Thomas RH; Michael BD;
    Lancet Psychiatry; 2020 Oct; 7(10):875-882. PubMed ID: 32593341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectrum of Neurological Manifestations in Covid-19: A Review.
    Garg RK
    Neurol India; 2020; 68(3):560-572. PubMed ID: 32643664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
    Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
    Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review.
    Montalvan V; Lee J; Bueso T; De Toledo J; Rivas K
    Clin Neurol Neurosurg; 2020 Jul; 194():105921. PubMed ID: 32422545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrovascular disease in patients with COVID-19: neuroimaging, histological and clinical description.
    Hernández-Fernández F; Sandoval Valencia H; Barbella-Aponte RA; Collado-Jiménez R; Ayo-Martín Ó; Barrena C; Molina-Nuevo JD; García-García J; Lozano-Setién E; Alcahut-Rodriguez C; Martínez-Martín Á; Sánchez-López A; Segura T
    Brain; 2020 Oct; 143(10):3089-3103. PubMed ID: 32645151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Environmental Issues and Neurological Manifestations Associated with COVID-19 Pandemic: New Aspects of the Disease?
    Bellocchio L; Bordea IR; Ballini A; Lorusso F; Hazballa D; Isacco CG; Malcangi G; Inchingolo AD; Dipalma G; Inchingolo F; Piscitelli P; Logroscino G; Miani A
    Int J Environ Res Public Health; 2020 Nov; 17(21):. PubMed ID: 33139595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
    Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
    Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
    Jha NK; Ojha S; Jha SK; Dureja H; Singh SK; Shukla SD; Chellappan DK; Gupta G; Bhardwaj S; Kumar N; Jeyaraman M; Jain R; Muthu S; Kar R; Kumar D; Goswami VK; Ruokolainen J; Kesari KK; Singh SK; Dua K
    J Mol Neurosci; 2021 Nov; 71(11):2192-2209. PubMed ID: 33464535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurological manifestations and complications of COVID-19: A literature review.
    Ahmad I; Rathore FA
    J Clin Neurosci; 2020 Jul; 77():8-12. PubMed ID: 32409215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
    Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
    Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurological Disorders Identified during Treatment of a SARS-CoV-2 Infection.
    Wada S; Nagasaki Y; Arimizu Y; Shimo M; Matsukuma Y; Okamoto M; Yoshida S; Ohashi I; Hashimoto G; Kuwashiro T; Yasaka M; Okada Y
    Intern Med; 2020 Sep; 59(17):2187-2189. PubMed ID: 32713924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.
    Yachou Y; El Idrissi A; Belapasov V; Ait Benali S
    Neurol Sci; 2020 Oct; 41(10):2657-2669. PubMed ID: 32725449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 95.